Start the conversation
Every year at this time, we tell you about the annual meeting of the American Society of Clinical Oncology (ASCO) - an event that's attended by 30,000 people and hosts 4,000 presentations.
We tell you about it because of the so-called "ASCO Effect" - a hefty surge in cancer-focused biotech stocks that always accompanies the start of this meeting.
And we usually recommend an oncology stock or two ourselves...
This is premium content for Private Briefing subscribers only.